Sale!

RR-TZ10 — 10mg | Research Use Only (RUO)

Original price was: $99.99.Current price is: $79.99.

Tirz (10mg) lyophilized powder. Dual-receptor agonist peptide for laboratory research applications. Purity ≥98%. Certificate of Analysis available.

47 in stock

SKU: RES-TIRZ-10 Category:

Description

A synthetic dual-receptor agonist peptide currently being investigated in controlled laboratory environments for its simultaneous interaction with incretin receptor signaling pathways.

For laboratory research use only. Not for human or animal consumption.

OVERVIEW

RR-TZ10 is a synthetic peptide studied in preclinical models for its interaction with two distinct receptor pathways: glucose-dependent insulinotropic polypeptide receptor (GIPR) and glucagon-like peptide-1 receptor (GLP-1R). Laboratory research has examined its dual-receptor binding characteristics, biased agonism profiles, and comparative signaling dynamics relative to single-receptor agonists under controlled experimental conditions.

Supplied as a lyophilized powder for analytical and experimental research applications.

PRODUCT SPECIFICATIONS

Compound: RR-TZ10
Quantity: 10 mg per vial
Form: Lyophilized powder
Purity: ≥98%
Storage: -20°C recommended, protect from light
CAS: 2023788-19-2

RESEARCH APPLICATIONS

– Dual-receptor agonist signaling studies
– GIP/GLP-1 receptor co-activation analysis
– Biased agonism and receptor selectivity research
– Comparative single vs. dual agonist pathway modeling

RESEARCH USE ONLY

This product is intended strictly for laboratory research purposes. Not for human consumption. Not for veterinary use. Not for therapeutic or diagnostic applications. Not intended to treat, cure, or prevent any condition. Use is limited to qualified professionals in controlled laboratory environments.

Certificate of Analysis available upon request.

Additional information

Weight 0.1 lbs
size

30mg

Reviews

There are no reviews yet.

Be the first to review “RR-TZ10 — 10mg | Research Use Only (RUO)”

Your email address will not be published. Required fields are marked *